Yahoo Finance

Insider Ownership: 16.1%

Earnings Growth Forecast: 55.3% p.a.

Shanghai Runda Medical Technology is forecasted to achieve significant earnings growth of 55.3% annually, surpassing the Chinese market's average. However, its recent financial performance showed declining revenue and net income, with profit margins dropping from 4.1% to 0.5%. Despite trading at a good value relative to peers, its debt coverage by operating cash flow is weak and dividend sustainability is questionable due to low earnings coverage. No substantial insider trading activity was reported recently.

• Click here to discover the nuances of Shanghai Runda Medical Technology with our detailed analytical future growth report.

• Our expertly prepared valuation report Shanghai Runda Medical Technology implies its share price may be lower than expected.

Zhejiang Jolly PharmaceuticalLTD

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zhejiang Jolly Pharmaceutical Co., LTD is involved in the research, production, and marketing of Chinese medicinal products both domestically and internationally, with a market cap of CN¥10.32 billion.

Operations: Zhejiang Jolly Pharmaceutical Co., LTD generates revenue from the research, production, and marketing of Chinese medicinal products within China and abroad.

Insider Ownership: 23.3%

Earnings Growth Forecast: 23.3% p.a.

Zhejiang Jolly Pharmaceutical is trading at 59% below its estimated fair value, presenting a good relative value compared to peers. Earnings grew by 45.4% over the past year, with revenue rising from CNY 1.46 billion to CNY 2.04 billion for the nine months ending September 2024. Despite earnings forecasted to grow slower than the market, revenue growth outpaces it at an expected annual rate of 22.5%. Recent shareholder meetings focused on stock incentive and ownership plans indicate strategic insider alignment with company growth objectives.

• Delve into the full analysis future growth report here for a deeper understanding of Zhejiang Jolly PharmaceuticalLTD.

• The analysis detailed in our Zhejiang Jolly PharmaceuticalLTD valuation report hints at an deflated share price compared to its estimated value.

Where To Now?

• Take a closer look at our Fast Growing Companies With High Insider Ownership list of 1466 companies by clicking here.

• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.

• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OB:MOWI SHSE:603108 and SZSE:300181.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com